S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Virax Biolabs Group (VRAX) Institutional Ownership

$0.68
-0.01 (-1.45%)
(As of 04/18/2024 ET)

Institutional Ownership Changes (13F Filings) for Virax Biolabs Group (NASDAQ:VRAX)

Current
Institutional Ownership
Percentage
8.61%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$10.61M
Number of
Institutional Sellers
(last 12 months)
0
Get VRAX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Virax Biolabs Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

VRAX Institutional Buying and Selling by Quarter

Virax Biolabs Group Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2024Armistice Capital LLC121,999$178K0.0%N/A7.871%
5/16/2023Armistice Capital LLC1,500,000$1.04M0.0%N/A9.648%
2/15/2023Virtu Financial LLC48,458$35K0.0%N/A0.378%
2/15/2023Legal & General Group Plc102,608$73K0.0%N/A0.800%
11/10/2022UBS Group AG12,196$38K0.0%N/A0.107%
(Data available from 1/1/2016 forward)

VRAX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of VRAX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Virax Biolabs Group shares: Armistice Capital LLC ($178K), Legal & General Group Plc ($73K), and UBS Group AG ($38K), Virtu Financial LLC ($35K).Learn more on VRAX's institutional investors.

What percentage of Virax Biolabs Group stock is owned by institutional investors?

8.61% of Virax Biolabs Group stock is owned by institutional investors. Learn more on VRAX's institutional investor holdings.

Which institutional investors have been buying Virax Biolabs Group stock?

The following institutional investors have purchased Virax Biolabs Group stock in the last 24 months: Armistice Capital LLC ($1.62M), Legal & General Group Plc ($102.61K), Virtu Financial LLC ($48.46K), and UBS Group AG ($12.20K).

How much institutional buying is happening at Virax Biolabs Group?

Institutional investors have bought a total of 1,785,261 shares in the last 24 months. This purchase volume represents approximately $12.10M in transactions.


This page (NASDAQ:VRAX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners